App-Based therapy aims to help stroke survivors regain speech

NCT ID NCT07397923

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a smartphone app called Zenicom that provides personalized speech therapy exercises for people who have trouble speaking after a stroke (aphasia). Twenty adults with recent stroke and aphasia will either receive standard speech therapy alone or standard therapy plus the app for two weeks. Researchers will measure changes in language ability to see if the app adds benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Zenicom digital speech therapy app
What this could lead to
If it works, this could provide a convenient, app-based way to improve language recovery for stroke survivors with aphasia.
What could go wrong
This is a very small, early-phase trial with only 20 participants. The treatment lasts only 2 weeks, so long-term benefits are unknown. It may not show significant improvement over standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Konkuk University Medical Center

    RECRUITING

    Seoul, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, South Korea

  • Seoul National University Bundang Hospital

    RECRUITING

    Seongnam-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.